 | Up a level |
Chung, Hyun Cheol and Kang, Yoon-Koo and Chen, Zhendong and Bai, Yuxian and Ishak, Wan Zamaniah Wan and Shim, Byoung Yong and Park, Young Lee and Koo, Dong-Hoe and Lu, Jianwei and Xu, Jianming and Chon, Hong Jae and Bai, Li-Yuan and Zeng, Shan and Yuan, Ying and Chen, Yen-Yang and Gu, Kangsheng and Zhong, Wen Yan and Kuang, Shu and Shih, Chie-Schin and Qin, Shu-Kui (2022) Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients. Cancer, 128 (5). pp. 995-1003. ISSN 0008-543X, DOI https://doi.org/10.1002/cncr.34019.
